Do lupus treatments block vaccine protection? french study investigates
NCT ID NCT04894253
Summary
This study aimed to understand how people with systemic lupus respond to COVID-19 vaccines. Researchers wanted to see if lupus disease activity or common lupus medications affect how well the body builds protective immunity after vaccination. The study was terminated early after enrolling only 7 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital of Hautepierre
Strasbourg, Bas-Rhin, 67000, France
Conditions
Explore the condition pages connected to this study.